Preferential effects of the chemotherapeutic DNA crosslinking agent mitomycin C on inducible gene expression in vivo
- 1 January 1995
- journal article
- research article
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 25 (1) , 4-11
- https://doi.org/10.1002/em.2850250103
Abstract
The immediate effects of a single dose of the chemotherapeutic DNA crosslinking agent, mitomycin C (MMC), on the expression of several constitutive and drug-inducible genes were examined in a simple in vivo system, the 14 day chick embryo. We observed no effect of MMC on the steady-state mRNA expression of the constitutively expressed β-action, transferrin, or albumin genes. In contrast, MMC treatment significantly altered both the basal and drug-inducible mRNA expression of two glutethimide-inducible genes, 5-aminolevulinic acid (ALA) synthase and cytochrome P450 CYP2H1. The basal expression of these genes was transiently but significantly increased over a 24 hr period following a single dose of MMC. Conversely, MMC significantly suppressed the glutethimide-inducible expression of these genes when administered 1 to 24 hr prior to the inducing drug. The effects of MMC on both basal and drug-inducible ALA synthase and CYP2H1 mRNA expression were principally a result of changes in the transcription rates of these genes. In contrast, MMC treatment had little or no effect on glutethimide-induced expression of ALA synthase or CYP2H1. when administered 1 hr after the inducing drug, suggesting that a very early event in the induction process represents the target for these MMC effects. Covalent binding studies demonstrated that the effects of MMC on gene expression were closely correlated temporally with formation of [3H]-porfiromycin-DNA adducts. These results support the hypothesis that genotoxic chemicals specifically target their effects to inducible genes in vivo.Keywords
This publication has 47 references indexed in Scilit:
- Detection of DNA adducts at the DNA sequence level by ligation-mediated PCRMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
- Preferential alteration of inducible gene expression in vivo by carcinogens that induce bulky DNA lesionsMolecular Carcinogenesis, 1993
- Different effectiveness of 4-nitroquinoline-1-oxide, mitomycin C and ethyl methanesulfonate to induce lesions in DNA leading to sister chromatid exchange throughout successive cell cycles in Chinese hamster ovary cellsMutagenesis, 1992
- Heterogeneity of DNA repair at the gene levelMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
- NMR and computational characterization of mitomycin cross-linked to adjacent deoxyguanosines in the minor groove of the d(T-A-C-G-T-A).cntdot.d(T-A-C-G-T-A) duplexBiochemistry, 1990
- Preferential modification of GC boxes by benzo[a]pyrene‐7,8‐diol‐9,10‐epoxideMolecular Carcinogenesis, 1989
- Ah receptor for 2,3,7,8‐ tetrachlorodibenzo‐p‐Dioxin: Ontogeny in chick embryo liverJournal of Biochemical Toxicology, 1986
- Preferential binding of the carcinogen benzo[a]pyrene to DNA in active chromatin and the nuclear matrixCarcinogenesis: Integrative Cancer Research, 1986
- Correlation between mixed-function oxidase enzyme induction and aflatoxin B1-induced unscheduled DNA synthesis in the chick embryo, in vivoEnvironmental Mutagenesis, 1984
- Actinomycin D‐binding in vivo: active chromatin preferredFEBS Letters, 1983